Therapeutic Potentials of Ecto‐Nucleoside Triphosphate Diphosphohydrolase, Ecto‐Nucleotide Pyrophosphatase/Phosphodiesterase, Ecto‐5′‐Nucleotidase, and Alkaline Phosphatase Inhibitors
Authors:
- 23 September 2013
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 34 (4) , 703-743
Abstract
The modulatory role of extracellular nucleotides and adenosine in relevance to purinergic cell signaling mechanisms has long been known and is an object of much research worldwide. These extracellular nucleotides are released by a variety of cell types either innately or as a response to patho‐physiological stress or injury. A variety of surface‐located ecto‐nucleotidases (of four major types; nucleoside triphosphate diphosphohydrolases or NTPDases, nucleotide pyrophosphatase/phosphodiesterases or NPPs, alkaline phosphatases APs or ALPs, and ecto‐5′‐nucleotidase or e5NT) are responsible for meticulously controlling the availability of these important signaling molecules (at their respective receptors) in extracellular environment and are therefore crucial for maintaining the integrity of normal cell functioning. Overexpression of many of these ubiquitous ecto‐enzymes has been implicated in a variety of disorders including cell adhesion, activation, proliferation, apoptosis, and degenerative neurological and immunological responses. Selective inhibition of these ecto‐enzymes is an area that is currently being explored with great interest and hopes remain high that development of selective ecto‐nucleotidase inhibitors will prove to have many beneficial therapeutic implications. The aim of this review is to emphasize and focus on recent developments made in the field of inhibitors of ecto‐nucleotidases and to highlight their structure activity relationships wherever possible. Most recent and significant advances in field of NTPDase, NPP, AP, and e5NT inhibitors is being discussed in detail in anticipation of providing prolific leads and relevant background for research groups interested in synthesis of selective ecto‐nucleotidase inhibitors.Keywords
This publication has 199 references indexed in Scilit:
- Cellular function and molecular structure of ecto-nucleotidasesPurinergic Signalling, 2012
- The GDA1_CD39 superfamily: NTPDases with diverse functionsPurinergic Signalling, 2011
- Distribution of NTPDase5 and NTPDase6 and the regulation of P2Y receptor signalling in the rat cochleaPurinergic Signalling, 2010
- Alkaline PhosphatasesPurinergic Signalling, 2006
- Physiological roles for ecto-5’-nucleotidase (CD73)Purinergic Signalling, 2006
- The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significancePurinergic Signalling, 2006
- Ecto-5’-nucleotidase: Structure function relationshipsPurinergic Signalling, 2006
- A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreactionPurinergic Signalling, 2005
- Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actinPurinergic Signalling, 2005
- Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8Purinergic Signalling, 2005